DNA Drug Design for Cancer Therapy

E-ISSN： 1873-4286|11|22|2811-2823

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.22, 2005-08, pp. : 2811-2823

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA-drug Conjugates for Site-specific Delivery in Anti-cancer Therapy

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 14, Iss. 2, 2017-04 ,pp. : 68-73

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetic Therapy: Histone Acetylation, DNA Methylation and Anti-Cancer Drug Discovery

Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. : 963-981

Bentham Science Publishers

Access to resources Recommend Favorite

G-quadruplex DNA: a potential target for anti-cancer drug design

By Han H. Hurley L.H.

Trends in Pharmacological Sciences, Vol. 21, Iss. 4, 2000-04 ,pp. : 136-142

Elsevier

Access to resources Recommend Favorite

Rational Drug Design of G-Quartet DNA as Anti-Cancer Agents

Current Pharmaceutical Design, Vol. 11, Iss. 22, 2005-08 ,pp. : 2841-2854

Bentham Science Publishers

Access to resources Recommend Favorite

DNA vaccines for cancer therapy

By Horton H.M. Parker S.E. Wloch M.K. Norman J.A.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2017-2026

Informa Healthcare

Access to resources Recommend Favorite